Capecitabine in the Perioperative Treatment of Rectal Cancer

NCT01500993 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

401

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer

Interventions

DRUG: Capecitabine
DRUG: 5-FU

Sponsor

Universitätsmedizin Mannheim